Articles published by MarketBeat
Seres Therapeutics’ SER-155 Posts 80% Response in Cancer Immunotherapy GI Toxicity Study ↗
Today 14:02 EDT
Via MarketBeat
Tickers
MCRB
Delta Air Lines Q2 Earnings Call Highlights ↗
Today 12:02 EDT
Via MarketBeat
Tickers
AVAV
Micron's $250 Billion Bet Could Reshape the AI Memory Race ↗
Today 11:10 EDT
Rocket Lab’s Stock Drop Comes With a Bullish Twist ↗
Today 10:35 EDT
Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement ↗
Today 10:02 EDT
Via MarketBeat
Tickers
FBRX
MTY Food Group Q2 Earnings Call Highlights ↗
Today 10:02 EDT
Amazon’s New Debt Deal Puts Its AI Spending Story on Trial ↗
Today 10:00 EDT
Velan Q1 Earnings Call Highlights ↗
Today 9:02 EDT
Via MarketBeat
Via MarketBeat
Via MarketBeat
Tickers
ESPR
PepsiCo’s Dividend Could Turn Patience Into Real Profit ↗
Today 7:35 EDT
Via MarketBeat
Tickers
PEP
DeFi Development Doubles Down on Solana Strategy as Crypto Volatility Spurs Cost Cuts ↗
Today 7:02 EDT
Via MarketBeat
Tickers
DFDV
Hays Q4 Earnings Call Highlights ↗
Today 6:03 EDT
Schroder Real Estate Invest H2 Earnings Call Highlights ↗
Today 6:03 EDT
Via MarketBeat
Topics
Earnings
Via MarketBeat
Tickers
CPRX
Via MarketBeat
Tickers
BLTE
Via MarketBeat
Tickers
AVAV
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting ↗
July 09, 2026
Via MarketBeat
Tickers
ACHV
WD-40 Q3 Earnings Call Highlights ↗
July 09, 2026
Aritzia Q1 Earnings Call Highlights ↗
July 09, 2026
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.